The clinical, biochemical and genetic data generated in the PoCCardio clinical trial are used to develop a computational AI-based tool for predicting the risk of a heart attack and therapy response in patients.
The clinical, biochemical and genetic data generated in the PoCCardio clinical trial are used to develop a computational AI-based tool for predicting the risk of a heart attack and therapy response in patients.